Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-027613
Filing Date
2025-03-25
Accepted
2025-03-25 10:48:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 17103
2 EXHIBIT 1 tm2510228d1_ex1.htm EX-1 10327
  Complete submission text file 0001104659-25-027613.txt   29345
Mailing Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Subject) CIK: 0001084201 (see all company filings)

EIN.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-79318 | Film No.: 25766309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTERTRUST CORP SVCS (CAYMAN) LTD 190 ELGIN AVENUE, GEORGE TOWN GRAND CAYMAN E9 KY 1-9005
Business Address C/O INTERTRUST CORP SVCS (CAYMAN) LTD 190 ELGIN AVENUE, GEORGE TOWN GRAND CAYMAN E9 KY 1-9005 1 345 749 8630
Advantech Capital L.P. (Filed by) CIK: 0001650757 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13D